Lymphoseek Approval History
- FDA approved: Yes (First approved March 13th, 2013)
- Brand name: Lymphoseek
- Generic name: technetium Tc 99m tilmanocept
- Company: Navidea Biopharmaceuticals
- Treatment for: Diagnosis and Investigation
Lymphoseek (technetium Tc 99m tilmanocept) Injection is a radioactive diagnostic agent indicated for lymphatic mapping with a hand-held gamma counter to assist in the localization of lymph nodes draining a primary tumor site in patients with breast cancer or melanoma.
FDA Approval History for Lymphoseek
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.